Background {#Sec1}
==========

With the improvement of people's living standards and medical standards, the life expectancy and the number of elderly persons in the China continues to increase. The aging population has its own special characteristics, which are gaining increased research attention \[[@CR1]\]. Generally speaking, elderly people over 75 years of age will experience reduced vital capacity, dysfunction of ventilation/blood flow ratio, osteoporosis, muscle atrophy, decreased muscle strength, decreased central regulatory function, reduced motor coordination, reduced strain control, and other pathophysiological changes, and the prevalence of degenerative diseases of the lumbar spine also increases \[[@CR2]\].

Degenerative disorders of the lumbar spine may cause significant neural compression, increased pain, and a decrease in the mobility and quality of life of elderly patients. Furthermore, to help maintain their independence, more elderly patients who have failed conservative treatment of their lumbar spinal disorder, are looking toward a surgical solution. It is increasingly important to identify interventions that are effective at improving the quality of life of elderly patients with spinal disorders \[[@CR3]\].

Lumbar fusion surgery is the main way for treating degenerative lumbar spine disorders; the surgical stress response associated with major surgery describes fundamental metabolic changes that lead to increased catabolism, immunosuppression, free radical production, and hypercoagulable states \[[@CR4]\]. These physiologic alterations have been linked to changes in organ function resulting in undesirable postoperative morbidity, complications, pain, fatigue, and extended convalescence \[[@CR5]\].

The benefits of enhanced recovery after surgery (ERAS) include reduction in the surgical stress response to minimize postoperative complications and after major surgery without increase in readmission rates, and increased patient satisfaction \[[@CR4]\]. These decrease the surgical stress responses and are of particular importance for the vulnerable patient with comorbidities, who are often also frail and elderly \[[@CR6]\]. Although ERAS has been shown to be effective for patients in general, few studies have addressed the effectiveness of ERAS in elderly patients with spinal disorders \[[@CR7]\].

There is no single surgical method applicable to all lumbar degenerative diseases. The elderly suffer from recurrence after aperture surgery due to the decreased elasticity of the intervertebral disk; lumbar fusion surgery has its own advantages in the treatment of degenerative spinal diseases in the elderly. The aim of this study was to determine whether ERAS could significantly improve care in the perioperative period and decrease perioperative complications, in-hospital length of stay (LOS), and 30-day readmission rates in elderly patients (\> 65 years old) with short-level lumbar fusion.

Materials and methods {#Sec2}
=====================

Inclusion criteria and patient selection {#Sec3}
----------------------------------------

This is a retrospective cohort study of prospectively collected data. The study protocol was approved by the Ethics Committee for Human Subjects of the Xuanwu Hospital of Capital Medical University (permit data 2018.4.3; no. 2018086). The study enrolled lumbar disk herniation or lumbar spinal stenosis patients if they were over the age of 65 years old underwent lumbar fusion at one or two levels from January 2018 to December 2019 (non-ERAS group), and between January to December 2019 (ERAS group). Both groups were cared for by the same surgical team. A retrospective non-ERAS group in which patients were treated under traditional perioperative protocols was case-matched to ERAS group. Diagnosis of degenerative disorders of the lumbar spine was performed by two spinal orthopedic specialists based on clinical symptoms and MRI images of the lumbar spine, which were used to identify the responsibility segments. Surgery was indicated when patients with typical symptoms of spinal stenosis did not respond to conservative treatments. Individuals who had infection disease, trauma, cauda equina injury, and neoplasm were excluded in this study, as well as those planned for a revision of a previous fusion.

Demographic data include age, gender, and body mass index (BMI). Comorbidities included hypertension, heart disease, diabetes, osteoporosis, stomach problem, bowel or intestinal problem, and psychological symptoms. Other interest included American Society of Anesthesiologists (ASA) physical status score, preoperative Japanese Orthopaedic Association Score (JOA), Oswestry Disability Index (ODI), and visual analogue score (VAS) for back and legs score. Operative records were reviewed to the number of fusion levels, operative time, and intraoperative blood loss. The primary outcome data that were analyzed included complication, length of stay, postoperative pain scores, and 30-day readmission rates. All data were collected from the electronic medical record.

ERAS interventions {#Sec4}
------------------

ERAS program was proposed and planned in 2017. The core group consisted of anesthesiologists, spine surgeons, nutritionists, physical therapists, physicians, geriatricians, and nurses. After literature review and experience discussion, a reasonable ERAS program was obtained. With the approval of the ethical committee for human subjects of the Xuanwu Hospital of Capital Medical University (Beijing, China), we began to implement the ERAS program in September 2018. Our ERAS interventions was divided into preoperative, intraoperative, and postoperative, included administration of the following: (1) patient education and counseling, (2) preoperative fasting, (3) antibiosis before surgery, (4) standard anesthetic protocol, (5) multimodal analgesia, (6) early feeding after surgery, (7) gastrointestinal management, (8) early mobilization medical, (9) early removal of bladder catheter, and (10) antithrombotic prophylaxis. The details of ERAS for pathway are presented in Table [1](#Tab1){ref-type="table"}. Table 1Patient demographicsPatient demographicsERASNon-ERAS*p*Sample size9595Age (years)72.39 ± 6.1270.81 ± 6.270.12Male/female45/5040/550.47Body mass index25.67 ± 3.3225.73 ± 4.000.93Smoker350.25**Comorbidities** Hypertension68740.32 Heart disease26240.74 Chronic lung disease020.16 Diabetes24310.26 Osteoporosis16150.84 Gastrointestinal850.39 Psychological symptoms320.65 Preoperative JOA8.30 ± 2.118,12 ± 1.900.59 Preoperative ODI, %60.89 ± 11.8858.88 ± 8.260.55 Preoperative VAS (back)7.15 ± 0.727.01 ± 0.700.25 Preoperative VAS (leg)7.06 ± 0.637.09 ± 0.590.56**ASA grade** I1310 II6873 III1412 IV00**No. of levels fusion** 144400.56 251550.56Operative time186.78 ± 57.38198.72 ± 69.480.58Intraoperative blood loss283.38 ± 195.44311.51 ± 219.440.42

Statistical analysis {#Sec5}
--------------------

All statistical analyses were performed using the SPSS software version 17.0 (SPSS, Inc., Chicago, IL, USA). Patient demographics, comorbidities data, markers of baseline health, and clinical outcomes were compared between ERAS group and non-ERAS group using Student's test and *χ*^2^ test. Multivariable linear regression analysis was used to assess the association of risk factors (ERAS elements) with LOS.

A value of *p* \< 0.05 was considered for significant differences.

Results {#Sec6}
=======

Demographics {#Sec7}
------------

A total of 192 patients were included, there were 96 patients in the ERAS group (45 men and 50 women, mean age 72.39 ± 6.12 years, mean BMI25.67 ± 3.32) and 96 patients in the non-ERAS group (40 men and 55 women, mean age 70.81 ± 6.27 years, mean BMI 25.73 ± 4.00). All surgeries were performed by a senior surgeon. Preoperative characteristics were similar between the two groups (Table [1](#Tab1){ref-type="table"}). Demographic data were compared, and no statistically significant intergroup differences were observed. And there were no significant differences with comorbidities, ASA grade, or the number of fusion levels. The mean ERAS group and non-ERAS group operative time and intraoperative blood loss showed no significant difference. In addition, the mean preoperative JOA, VAS for the back and legs, and ODI score showed no significant difference (Table [1](#Tab1){ref-type="table"}).

Compliance to ERAS pathway {#Sec8}
--------------------------

Our ERAS protocol included 12 elements interventions overall pathway compliance was 92.1% (Table [2](#Tab2){ref-type="table"}). Patient education and counseling, no prolonged fasting, antimicrobial prophylaxis, and all intraoperative ERAS items were used in 100% of cases. The item with the lowest compliance was early removal of bladder catheter (52.6%). Table 2ERAS pathway complianceCompliance with the ERAS programVariable*n* (%)Preoperative ERAS items Patient education and counseling95 (100) No prolonged fasting95 (100) Fluid and carbohydrate loading90 (94.7) Antithrombotic stockings95 (100) Antimicrobial prophylaxis95 (100)Intraoperative ERAS items Tranexamic acid95 (100) Maintenance of normothermia95 (100) Local infiltration analgesia95 (100)Postoperative ERAS items Early ambulation63 (66.3) Early removal of bladder catheter50 (52.6) Early oral feeding70 (73.7) Perioperative multimodal analgesia93 (97.9) Overall compliance (rate)92.1

Outcomes {#Sec9}
--------

The main clinical outcomes are shown in Table [3](#Tab3){ref-type="table"}, after the implementation of ERAS, there was no significant difference in complication and mortality between ERAS group and non-ERAS group. Furthermore, the mean postoperative JOA, VAS for the back and legs, ODI, and readmission rates score showed no significant difference at 30-day follow-up, as complete data were available for 83% of patients at this early time point. However, we observed a statistically significant decrease in LOS in the ERAS group (12.30 ± 3.03 in ERAS group versus 15.50 ± 1.88 in non-ERAS group, *p* = 0). Multivariable linear regression showed that comorbidities (*p* = 0.023) and implementation of ERAS program (*p* = 0.002) were correlated with prolonged LOS. On the other hand, age (*p* = 0.379), sex (*p* = 0.085), BMI (*p* = 0.535), smoker (*p* = 0.137), ASA ≥ 3 (*p* = 0.062), fusion number (*p* = 0.236), operative time (*p* = 0.151), blood loss (*p* = 0.079), preoperative JOA (*p* = 0.235), preoperative VAS back (*p* = 0.949), preoperative VAS leg (*p* = 0.656), and preoperative ODI (*p* = 0.179) were not related to LOS. Multivariable logistic regression showed that no characteristics were associated with complications (Table [4](#Tab4){ref-type="table"}). Table 3Postoperative outcomesOutcome measureERASNon-ERAS*p***Complications** Cerebrovascular accident010.32 Cardiac arrest00 Deep vein thrombosis010.32 Surgical site infection140.17 Spinal fluid leakage120.56 Neurological111LOS12.30 ± 3.0315.50 ± 1.88030-day readmissions1130-day mortality00Table 4Multivariable analyses for LOS and complicationsCharacteristicMultivariable linear regression for LOSMultivariable logistic regression for any complicationsCoefficient (95% CI)*p* valueOR (95% CI)*p* valueAge0.24 (− 0.13 to 0.26)0.3791.15 (0.89--1.26)0.563Female1.28 (− 0.51 to 1.10)0.0851.07 (0.91--1.14)0.210BMI− 0.033 (− 0.13 to 0.07)0.5350.97 (0.92--1.06)0.085Smoker0.76 (− 0.21 to 1.11)0.1372.10 (0.85--3.24)0.121Comorbidities1.26 (0.29 to 2.23)0.0231.56 (0.77--2.91)0.074ASA ≥  30.98 (− 0.03 to 1.92)0.0622.31 (0.98--4.53)0.060Fusion number2.15 (− 1.29 to 3.37)0.2361.98 (0.91--2.58)0.140Operative time0.36 (− 0.19 to 1.08)0.1511.33 (0.86--3.46)0.088Blood loss1.12 (− 2.56 to 4.95)0.0791.44 (0.65--1.90)0.872ERAS− 2.98 (− 3.76 to − 1.64)0.0020.72 (0.31--1.09)0.077Preoperative JOA0.34 (− 0.46 to 0.88)0.2350.81 (0.70--1.34)0.179Preoperative VAS (back)0.65 (− 0.70 to 2.01)0.9491.12 (0.81--2.03)0.235Preoperative VAS (leg)0.98 (0.01 to 1.37)0.6562.09 (0.95--2.71)0.068Preoperative ODI (%)− 0.02 (− 0.07 to 0.01)0.1791.36 (0.74--2.28)0.307

Discussion {#Sec10}
==========

A loss of disk height occurs with aging and may place non-physiological loads on adjacent segments as well as the facet joints, a common source of low back pain. Low back pain and sciatica can significantly impair psychosocial functioning, lead to sleep disorders and depressive symptoms, and may be linked to coronary heart disease, particularly in elderly persons \[[@CR8]\]. However, due to poor physical function and comorbidities of the elderly persons, the lumbar spinal surgery in elderly patients has been associated with high rates of perioperative complications \[[@CR9]\]. Worley et al. found that patients age \> 65 had an increased risk of inpatient morbidity \[[@CR10]\]. Initially proposed by Danish surgeon, Henrik Kehle, ERAS is a multi-professional and multidisciplinary approach to the care of the surgical patient in order to obtain a rapid recovery after surgical intervention \[[@CR11]\]. While the initial efforts focused on colorectal surgery, the basic principles have now been adopted to multiple surgical specialties \[[@CR6], [@CR12]--[@CR14]\]. ERAS protocols have been shown to be particularly beneficial for the elderly people who often have comorbidities and run a higher risk of surgical complications. Furthermore, these principles have been applied in patients with total hip arthroplasty, total knee arthroplasty, and those with intertrochanteric fracture, who not only experienced reduced hospital LOS, but also in improvement in patient care and reduced health care costs \[[@CR15], [@CR16]\].

At its core, the ERAS program aims at faster recovery, and LOS was used as the primary efficacy parameter. This study showed that application of ERAS in elderly patients with short-level lumbar fusion could decrease the LOS.

Shorting fasting and feeding time is one of important preoperative elements in our ERAS program. Because of perioperative starvation induces stress hormones release of the inflammatory cytokine and the accumulation of lipid products in skeletal muscles, traditional preoperative fasting for at least 8 h and oral feeding on postoperative 1 day may cause insulin resistance and metabolic stress \[[@CR17], [@CR18]\]. Insulin resistance and metabolic stress could increase the rate of postoperative complications \[[@CR19]\]. Shortening preoperative fasting and postoperative eating time may shifts cellular metabolism to a more anabolic state \[[@CR20]\]. Therefore, it can minimize protein loss, improve patient comfort, and decrease insulin resistance \[[@CR21]\]. Good nutritional status could reduce the occurrence of complications such as wound infections and may help wound healing \[[@CR22]\]. Research examining shortening preoperative fasting and postoperative eating time of elderly patients with lumbar surgery is markedly lacking, despite studies indicating that it is safe and effective \[[@CR1], [@CR18], [@CR23]\]. Our studies showed that elderly patients with oral carbohydrate drink 2 h before the induction anesthesia and after surgery drinking water starting 2--4 h and early feeding started at 6 h is safe and without increasing complications.

Compared to other reports of ERAS in spine surgery, our ERAS program early mobilization compliance was high. Early mobilization is considered a key element of postoperative care in our ERAS program. Traditional long stay in bed was associated with infections and muscle weakness. Although a wealth of data confirms that early mobility could reduce the incidence of many of these complications and that early mobility within 24 h after spinal surgery is safe \[[@CR24]--[@CR26]\], there are few studies that investigate how early elderly patients can safely get out of bed and ambulate, and the way of the elderly patients get out of bed and ambulate. In this study, our early mobility protocol was from sitting out of bed or walking with assistance to walking without assistance within 24 h. Early mobilization following surgery has multiple benefits including improved ventilation, muscle strength, and functional capacity \[[@CR24]\]; our results showed that early mobilization in elderly patients after short-level lumbar fusion is safe and without increasing complications and 30-day readmission rates.

However, this study has several limitations. This study is the retrospective design, small sample size. Given the lack of long-term follow-up data, definitive conclusions cannot be drawn beyond a 30-day period. Furthermore, the ERAS and non-ERAS groups were assessed at different times, which may have introduced analytical bias. Further multicenter studies with a larger participant population are required to confirm the safety and efficacy of our ERAS protocol in elderly patients after short-level lumbar fusion surgery.

Conclusions {#Sec11}
===========

In conclusion, this report describes the first ERAS protocol used in elderly patients after short-level lumbar fusion surgery. Our ERAS program is safe and could help decreases LOS in elderly patients with short-level lumbar fusion. Further studies with more participants are required to validate these findings. While still in its infancy, with modified approaches to our ERAS protocol, will likely improve adherence to the protocol and outcomes.
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